Your session is about to expire
← Back to Search
Behavioural Intervention
Effect of Increasing Motor Cortex Inhibition on Task Specific Dystonia
N/A
Waitlist Available
Led By Cathrin Buetefisch, MD, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 weeks (2 visits)
Summary
This trial uses a device called TMS to help people with hand muscle problems like writer's cramp. TMS changes brain activity to reduce unwanted muscle movements. The study will measure how well this works and if it helps improve hand function. TMS is a non-invasive tool that has been increasingly used to study and treat brain-related conditions, including writer's cramp.
Eligible Conditions
- Dystonia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 weeks (2 visits)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 weeks (2 visits)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Efficacy of TMS on task-specific focal hand dystonia
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: rTMSActive Control1 Intervention
rTMS condition, rTMS will be applied at 0.1-0.5 Hz frequency at a subthreshold intensity
Group II: rTMS shamPlacebo Group1 Intervention
Placebo condition will use a sham coil and apply a very small magnetic stimulus
Find a Location
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,704 Previous Clinical Trials
2,607,283 Total Patients Enrolled
6 Trials studying Dystonia
3,870 Patients Enrolled for Dystonia
Cathrin Buetefisch, MD, PhDPrincipal InvestigatorEmory University
3 Previous Clinical Trials
168 Total Patients Enrolled